These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19857670)

  • 1. Association of the A1936G (rs203462) of A-kinase anchoring protein 10 polymorphisms with QT interval prolongation during kidney transplantation.
    Zukowski M; Bohatyrewicz R; Biernawska J; Kotfis K; Knap R; Kaczmarczyk M; Ciechanowicz A; Binczak A; Brykczyński M
    Transplant Proc; 2009 Oct; 41(8):3036-8. PubMed ID: 19857670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of rs10918594 polymorphisms of nitric oxide synthase 1 adaptor protein (NOS1AP) with QTc interval prolongation during kidney transplantation.
    Kaczmarczyk M; Biernawska J; Zukowski M; Kotfis K; Zegan-Barańska M; Bińczak-Kuleta A; Ciechanowicz A; Brykczyński M; Bohatyrewicz R
    Transplant Proc; 2011 Oct; 43(8):2964-6. PubMed ID: 21996201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 and the risk of colorectal cancer.
    Wang MJ; Zhou ZG; Wang L; Yu YY; Zhang P; Zhang Y; Cui CF; Yang L; Li Y; Zhou B; Sun XF
    Oncology; 2009; 76(3):199-204. PubMed ID: 19209010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
    Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged QT interval and reduced heart rate variability in patients with uncomplicated essential hypertension.
    Maule S; Rabbia F; Perni V; Tosello F; Bisbocci D; Mulatero P; Veglio F
    Hypertens Res; 2008 Nov; 31(11):2003-10. PubMed ID: 19098371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genotyping of AKAP10 gene 2073A/G single nucleotide polymorphism by TaqMan probe real-time PCR].
    Wang MJ; Zhou ZG; Wang L; Li Y; Zhang P; Zhang Y; Cui CF; Zhou B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):275-8. PubMed ID: 19462906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5 HT(3)-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalities.
    Quraishi SA; Schuler GH; Janicki PK
    J Clin Anesth; 2011 Jun; 23(4):297-302. PubMed ID: 21663814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta1-adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome.
    Paavonen KJ; Swan H; Piippo K; Laitinen P; Fodstad H; Sarna S; Toivonen L; Kontula K; Viitasalo M
    Int J Cardiol; 2007 May; 118(2):197-202. PubMed ID: 17023080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic basis of long QT and short QT syndromes: a mutation update.
    Hedley PL; Jørgensen P; Schlamowitz S; Wangari R; Moolman-Smook J; Brink PA; Kanters JK; Corfield VA; Christiansen M
    Hum Mutat; 2009 Nov; 30(11):1486-511. PubMed ID: 19862833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation.
    van Noord C; Aarnoudse AJ; Eijgelsheim M; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    Pharmacogenet Genomics; 2009 Apr; 19(4):260-6. PubMed ID: 19247217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common genetic variants in ANK2 modulate QT interval: results from the KORA study.
    Sedlacek K; Stark K; Cunha SR; Pfeufer A; Weber S; Berger I; Perz S; Kääb S; Wichmann HE; Mohler PJ; Hengstenberg C; Jeron A
    Circ Cardiovasc Genet; 2008 Dec; 1(2):93-9. PubMed ID: 20031550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT interval and QT dispersion in systemic sclerosis (scleroderma).
    Sgreccia A; Morelli S; Ferrante L; Perrone C; De Marzio P; De Vincentiis G; Scopinaro F
    J Intern Med; 1998 Feb; 243(2):127-32. PubMed ID: 9566641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype.
    Lande G; Kyndt F; Baró I; Chabannes D; Boisseau P; Pony JC; Escande D; Le Marec H
    Eur Heart J; 2001 Mar; 22(5):410-22. PubMed ID: 11207083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.
    Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Radovancevic B
    J Card Fail; 2005 Dec; 11(9):684-90. PubMed ID: 16360963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of maximum corrected QT and corrected QT dispersion in electrocardiography after kidney transplantation.
    Monfared A; Ghods AJ
    Iran J Kidney Dis; 2008 Apr; 2(2):95-8. PubMed ID: 19377216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT interval correction in patients with cirrhosis.
    Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
    J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.